
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Research Articles |
Authors' Affiliations: 1 Department of Pathology, 2 Division of Urology and Duke Prostate Center, Department of Surgery, 3 Center for Genomic Medicine, Institute for Genome Sciences and Policy, 4 Department of Medicine, 5 Duke Comprehensive Cancer Center, 6 Division of Experimental Surgery, Department of Surgery, and 7 Department of Surgery, Durham VA Medical Center, Duke University Medical Center, Durham, North Carolina; 8 Department of Oncology, Lady Davis Research Institute, McGill University, Montreal, Canada; 9 Department of Pediatrics, University of California at Los Angeles School of Medicine, Los Angeles, California; and 10 Department of Behavioral Science, The University of Texas M. D. Anderson Cancer Center, Houston, Texas
Requests for reprints: Stephen Freedland, Box 2626, Duke University Medical Center, Durham, NC 27710. Phone: 919-668-8361; Fax: 919-668-7093; E-mail: steve.freedland{at}duke.edu.
Purpose: Numerous dietary factors elevate serum levels of insulin and insulin-like growth factor I (IGF-I), both potent prostate cancer mitogens. We tested whether varying dietary carbohydrate and fat, without energy restriction relative to comparison diets, would slow tumor growth and reduce serum insulin, IGF-I, and other molecular mediators of prostate cancer in a xenograft model.
Experimental Design: Individually caged male severe combined immunodeficient mice (n = 130) were randomly assigned to one of three diets (described as percent total calories): very high-fat/no-carbohydrate ketogenic diet (NCKD: 83% fat, 0% carbohydrate, 17% protein), low-fat/high-carbohydrate diet (LFD: 12% fat, 71% carbohydrate, 17% protein), or high-fat/moderate-carbohydrate diet (MCD: 40% fat, 43% carbohydrate, 17% protein). Mice were fed to maintain similar average body weights among groups. Following a preliminary feeding period, mice were injected with 1 x 106 LNCaP cells (day 0) and sacrificed when tumors were
1,000 mm3.
Results: Two days before tumor injection, median NCKD body weight was 2.4 g (10%) and 2.1 g (8%) greater than the LFD and MCD groups, respectively (P < 0.0001). Diet was significantly associated with overall survival (log-rank P = 0.004). Relative to MCD, survival was significantly prolonged for the LFD (hazard ratio, 0.49; 95% confidence interval, 0.29-0.79; P = 0.004) and NCKD groups (hazard ratio, 0.59; 95% confidence interval, 0.37-0.93; P = 0.02). Median serum insulin, IGF-I, IGF-I/IGF binding protein-1 ratio, and IGF-I/IGF binding protein-3 ratio were significantly reduced in NCKD relative to MCD mice. Phospho-AKT/total AKT ratio and pathways associated with antiapoptosis, inflammation, insulin resistance, and obesity were also significantly reduced in NCKD relative to MCD tumors.
Conclusions: These results support further preclinical exploration of carbohydrate restriction in prostate cancer and possibly warrant pilot or feasibility testing in humans.
Key Words: prostate cancer diet carbohydrate fat ketogenic insulin IGF-I AKT
This article has been cited by other articles:
![]() |
S. J. Freedland, C. D. Williams, and E. M. Masko Adiponectin and Prostate Cancer Mortality: To Be or Not to Be Skinny? Clin. Chem., January 1, 2010; 56(1): 1 - 3. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |